Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > VRAX Virax Biolabs > Detailed Quotes

VRAX Virax Biolabs

Watchlist
6.710
-0.560-7.70%
Close 08/16 16:00 ET
6.720
+0.01+0.15%
Post Mkt Price 08/16 19:46 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
7.282
Open
7.250
Turnover
2.33M
Low
6.570
Pre Close
7.270
Volume
339.62K
Market Cap
76.32M
P/E(TTM)
Loss
52wk High
29.000
Shares
11.37M
P/E(Static)
Loss
52wk Low
5.400
Float Cap
9.06M
Bid/Ask %
0.00%
Historical High
29.000
Shs Float
1.35M
Volume Ratio
0.43
Historical Low
5.400
Dividend TTM
--
Div Yield TTM
--
P/B
-78.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
25.16%
Amplitude
9.80%
Avg Price
6.865
Lot Size
1
Float Cap
9.06M
Bid/Ask %
0.00%
Historical High
29.000
Shs Float
1.35M
Volume Ratio
0.43
Historical Low
5.400
Dividend TTM
--
P/B
-78.02
Dividend LFY
--
Turnover Ratio
25.16%
Amplitude
9.80%
Avg Price
6.865
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, and individual consumers. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. The company was incorporated in 2021 and is based in London, the United Kingdom.
CEO: Foster, James
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top